Related Post
Journal Reports: Investing Regular
AARP-Branded Medicare Drug Plan Is Also High priced for Numerous Retirees, Critics Say
By R, andall Smith
November 4, 2022 at 2:00 PM ET
The preferred plan’s value has risen sharply in current years—prompting some professionals to propose enrollees look at switching.
Tags: Burton MalkielC&E Exclusion FiltercommodityCommodity/Financial Market NewsContent TypesEquity MarketsExchange Traded FundsFactiva Filtersfinancial market newsFinancial Servicesfinancial vehiclesfundsimreportinvestingInvesting/Securitiesjournal reportssecuritiessyndtrustsTrusts/Funds/Financial VehiclesWSJ-PRO-WSJ.com